Literature DB >> 3807220

[Blepharospasm treatment with botulinum toxin (follow-up)].

P Roggenkämper.   

Abstract

Within a period of 14 months 73 patients with idiopathic blepharospasm which could not be treated satisfactorily by any other form of therapy were treated by injections of botulin toxin. In 55 cases the follow-up period was sufficiently long to permit an evaluation. Thirty-five patients were temporarily completely free of complaints; in one patient there was no improvement. In the remaining cases there was a slight to distinct reduction in symptoms, which often cause severe suffering. The full effect of the drug lasted between 1 and 27 weeks (average 7.5 weeks). No systemic side-effects were observed; local side-effects (subcutaneous bleeding during injection, slight ptosis, intermittent diplopia) seen in 6 cases were of very minor significance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3807220     DOI: 10.1055/s-2008-1050804

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  9 in total

1.  [Pharmacology of botulinum toxin drugs].

Authors:  D Dressler
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

2.  [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].

Authors:  P Roggenkämper
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

Review 3.  A brief history of neurological botulinum toxin therapy in Germany.

Authors:  Dirk Dressler; Peter Roggenkaemper
Journal:  J Neural Transm (Vienna)       Date:  2017-07-21       Impact factor: 3.575

Review 4.  [Use of botulinum toxin in strabismus].

Authors:  B Wabbels
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

5.  Frontalis suspension in the treatment of essential blepharospasm unresponsive to botulinum-toxin therapy: long-term results.

Authors:  P Roggenkämper; Z Nüssgens
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-08       Impact factor: 3.117

Review 6.  [Botulinum toxin A in orthopedic pain therapy].

Authors:  R Placzek; M Söhling; M Gessler; J Jerosch
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

7.  Orbicular synkinesis after facial paralysis: treatment with botulinum toxin.

Authors:  P Roggenkämper; R Laskawi; W Damenz; M Schröder; Z Nüssgens
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

8.  Beneficial effect of botulinum A toxin in blepharospasm: 16 months' experience with 16 cases.

Authors:  S Maurri; S Brogelli; G Alfieri; F Barontini
Journal:  Ital J Neurol Sci       Date:  1988-08

9.  Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A-30 Years of Experience in a Tertiary Care Center.

Authors:  Bettina Wabbels; Rolf Fimmers; Peter Roggenkämper
Journal:  Toxins (Basel)       Date:  2022-02-07       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.